abstract |
The present invention is a therapeutic agent for preventing and / or treating cancer, autoimmune diseases, fibrotic diseases, inflammatory diseases, neurodegenerative diseases, infectious diseases, lung diseases, heart and vascular diseases and metabolic diseases. Of Asp-Leu-Arg-Val-Asp-Thr-Lys-Ser-Arg-Ala-Ala-Trp-Ala-Arg-Leu-Leu-Gln-Glu-His-Pro-Asn-Ala-Arg-Lys- Tyr-Lys-Gly-Ala-Asn-Lys-Lys-Gly-Leu-Ser-Lys-Gly-Cys-Phe-Gly-Leu-Lys-Leu-Asp-Arg-Ile-Gly-Ser-Met-Ser- It relates to the use of peptide compounds of Gly-Leu-Gly-Cys-OH. Furthermore, the present invention relates to Asp-Leu-Arg-Val-Asp-Thr-Lys-Ser-Arg-Ala-Ala-Trp-Ala-Arg-Leu-Leu-Gln-Glu-His-Pro-Asn-Ala- Arg-Lys-Tyr-Lys-Gly-Ala-Asn-Lys-Lys-Gly-Leu-Ser-Lys-Gly-Cys-Phe-Gly-Leu-Lys-Leu-Asp-Arg-Ile-Gly-Ser- Met-Ser-Gly-Leu-Gly-Cys-OH peptide and optionally at least one pharmaceutically acceptable carrier, at least one cryoprotectant, at least one dispersion protectant, at least one supplement. It relates to a pharmaceutical composition comprising a dosage form and / or at least one diluent, preferably in the form of a lyophilizate, buffer, artificial breast milk formulation or breast milk substitute. |